DE1359854U - - Google Patents

Info

Publication number
DE1359854U
DE1359854U DENDAT1359854D DE1359854DU DE1359854U DE 1359854 U DE1359854 U DE 1359854U DE NDAT1359854 D DENDAT1359854 D DE NDAT1359854D DE 1359854D U DE1359854D U DE 1359854DU DE 1359854 U DE1359854 U DE 1359854U
Authority
DE
Germany
Prior art keywords
jin
ftt
vstorn
tßn
tttplt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1359854D
Other languages
German (de)
English (en)
Publication of DE1359854U publication Critical patent/DE1359854U/de
Active legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Prostheses (AREA)
  • Dental Preparations (AREA)
DENDAT1359854D Active DE1359854U (https=)

Publications (1)

Publication Number Publication Date
DE1359854U true DE1359854U (https=)

Family

ID=673895

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1359854D Active DE1359854U (https=)

Country Status (1)

Country Link
DE (1) DE1359854U (https=)

Similar Documents

Publication Publication Date Title
DE1359854U (https=)
CA2350246C (en) Controlled delivery of active agents
US5897878A (en) Method for administering steroid
US4915953A (en) Dosage form for delivering acetaminophen or phenylpropanolamine
US5830502A (en) Injection-molded dosage form
CA1288016C (en) Dosage form comprising fast agent delivery followed by slow agent delivery
US8309125B2 (en) Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
AU619454B2 (en) Dispenser comprising displaceable matrix with solid state properties
US4940465A (en) Dispenser comprising displaceable matrix with solid state properties
IE892845A1 (en) Controlled-release oral dosage forms comprising different cellulose ethers
CA2499597C (en) Multistage formulation containing a biguanide and thiazolidindione derivatives
EP0581862A1 (en) PHARMACEUTICAL FORMS COMPRISING POLYMERS HAVING DIFFERENT MOLAR MASSES.
US4732915A (en) Process for increasing solubility of drug
US5266332A (en) Method for administering anti-Parkinson drug
US4610686A (en) Controlled delivery of haloperidol by an osmotic delivery system
IL297368A (en) Long-acting peptide tyrosine kinase (pyy) analogs and methods of use
EP2848245A1 (en) Bosentan controlled release oral preparation
KR101010325B1 (ko) 텔미사르탄 및 히드로클로로티아지드를 함유하는 약제학적 조성물
DE1460624U (https=)
DE1401201U (https=)
DE1530839U (https=)
DE1438762U (https=)
DE1455910U (https=)
AU731358B2 (en) Injection-molded dosage form
DE1288387U (https=)